What is Optimal for Antibiotic Studies in Acute Otitis Media?

Garrison GD Sorum PC Hioe W Miller MM. High-dose versus standard-dose amoxicillin for acute otitis media. Ann Pharmacother 2004;38:15–9. DOI 10.1345/aph.1D052.

Dowell SF Butler JC Giebink GS Jacobs MR Jernigan D Musher DM Acute otitis media: Management and surveillance in an era of pneumococcal resistance-a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999;18:1–9.

Marchant CD. Design of clinical trials of antibiotic therapy for acute otitis media. FDA Anti-Infective Drugs Advisory Committee Meeting, Department of Health and Human Services, FDA Center for Drug Evaluation and Research. July 11, 2002. www.fda.gov/ohrms/dockets/ac/02/transcripts/3875T2.htm (accessed 2003 Sept 19).

Marchant CD Carlin SA Johnson CE Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: The “Pollyanna phenomenon.” J Pediatr 1992;120:72–7.

Rosenfeld RM. An evidence-based approach to treating otitis media. Pediatr Clin North Am 1996;43:1165–81.

Schrag SJ Peña C Fernandez J Sanchez J Gomez V Perez E Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: A randomized trial. JAMA 2001;286:49–56.

Anti-Infective Drugs Advisory Committee, Department of Health and Human Services, FDA Center for Drug Evaluation and Research. July 11, 2002. www.fda.gov/ohrms/dockets/ac/02/transcripts/3875T2.htm (accessed 2003 Sept 19).

Little P Gould C Moore M Warner G Dunleavey J Williamson I. Predictors of poor outcome and benefits from antibiotics in children with acute otitis media: Pragmatic randomised trial. BMJ 2002;325:22–5.

Little P Gould C Williamson I Moore M Warner G Dunleavey J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ 2001;322:336–42.

Siegel RM Kiely M Bien JP Joseph EC Davis JB Mendel SG Treatment of otitis media with observation and a safety-net antibiotic prescription. Pediatrics 2003;112:527–31.

Erramouspe J Heyneman CA. Treatment and prevention of otitis media. Ann Pharmacother 2000;34:1452–68. DOI 10.1345/aph.19391.